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Background: The impact of minimized extracorporeal circulation (MECC) for emergency revascularization remains
controversial.
Methods: A total of 348 patients underwent emergency CABG with MECC (n=146) or conventional extracorporeal
circulation (CECC; n=175) between January 2005 and December 2010. Using propensity score matching after binary
logistic regression, 100 patients, who underwent CABG with MECC could be matched with 100 patients, who
underwent CABG with CECC. Primary outcome was 30-day mortality.
Results: Unadjusted 30-day mortality was 14.8% in patients with CECC and 6.9% in those with MECC (mean
difference −7.9%; p=0.03). The adjusted mean difference (average treatment effect of the treated, ATT) after
matching was −1.0% (95% CI −8.6 to 7.6; p=1.0). Intensive care unit stay (adjusted mean difference 1.0; 95% CI −0.2
to 3.2; p=0.70) and hospital stay (adjusted mean difference 1.0; 95% CI −2.0 to 3.6; p=0.40) did not show significant
differences between both groups. The adjusted mean difference for postoperative low cardiac output syndrome
was −1.1% (95% CI −7.3 to 7.1; p=0.83) without significant differences between CECC and MECC. Postoperative
mechanical ventilation time, drain loss, postoperative rethoracotomy, postoperative neurological events, new onset
renal replacement therapy and respiratory failure also had insignificant average treatment effects of the treated. In
addition, all average treatment effects (ATEs) did not significantly differ between both groups.
Conclusion: Using propensity score estimation and matching, we did not observe significant differences in terms
of survival and further outcomes in patients who undergo emergency CABG with CECC or MECC, but our results
call for further analysis.
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Coronary artery bypass grafting (CABG) with cardiopulmo-
nary bypass support (CPB) as standard perfusion technique
remains the treatment of choice for high-grade left main-
stem stenosis and triple-vessel coronary artery disease [1,2].
Several studies compared the impact of minimized versus
conventional extracorporeal circuits and found conflicting
results. Development and utilization of MECC have been
proposed to reduce the adverse effects of CECC during* Correspondence: micha.ried@t-online.de
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reproduction in any medium, provided the orCABG while taking the advantages of standard ECC [3-5].
Various publications have reported that MECC decreases
perioperative side effects such as systemic inflammation,
coagulation derangement and postoperative complications
[6-8], whereas other reports failed to confirm these promis-
ing results [9]. Our department has been performing CABG
with MECC for more than one decade and we could dem-
onstrate that MECC is a safe alternative for on-pump and
off-pump coronary revascularization [10]. Even in high-risk
patients MECC using could be successfully applied [11].
However, emergency patients suffering from an acute
coronary syndrome are at high-risk and perioperatived. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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standard ECC [12]. Recent studies reported a survival
benefit in this high-risk group of patients by performing
beating-heart or off-pump coronary revascularization
[13-15]. Nevertheless, application of MECC in patients
emergency CABG remains controversial and no evidence
suggests using MECC for emergency CABG.
Purpose of the present study was to examine the feasi-
bility and efficacy of minimized ECC use in patients
undergoing emergency surgical revascularization. Pro-
pensity score matching reduced significant selection bias
between both groups and enabled direct comparison.
Methods
Patients and study design
From January 2005 to December 2010 a total of 321
consecutive patients who underwent emergency coron-
ary artery bypass graft surgery (CABG) at the University
Medical Center Regensburg were studied. The study was
approved by the university’s ethics board, the individual
patients consent was waived because of the study’s retro-
spective design and data collection from routine care.
Included were only patients with emergency presenta-
tion due to acute coronary syndrome (unstable angina,
non-ST-segment and ST-segment elevation myocardial in-
farction, elevated myocardial markers) which prompted
isolated CABG within 24 hours after hospital admission.
Acute myocardial infarction was diagnosed by conven-
tional 12-channel electrocardiography in addition to myo-
cardial enzymes and confirmed by immediate coronary
angiography. All patients were evaluated for percutaneous
coronary intervention (PCI). Coronary lesions (left main-
stem stenosis, complicated and multiple lesions) were
unsuitable for primary PCI. CABG procedures were
performed with conventional (CECC) or minimized extra-
corporeal circulation (MECC) under general anesthesia.
Patients with severe aortic regurgitation, a body mass
index (BMI) ≥ 35 kg × m-2 and renal end-stage failure
were relative contraindications for MECC support.
Complete surgical revascularization was the aim in all pa-
tients and hybrid procedures were not primarily indicated.
Exclusion criteria were as follows: elective CABG, conver-
sion to surgical correction after failed PCI, beating-heart
techniques, off-pump revascularization (OPCAB), redo
surgery and preoperative renal replacement therapy. All
operations were performed by six senior surgeons who are
experienced in CABG with conventional as well as mini-
mized extracorporeal circulation.
Data collection
Patients’ data were collected prospectively in and retro-
spectively extracted from the institution’s database and
from medical records, including demographic, clinical
and outcome data. Variables were defined according tothe European System of Cardiac Operative Risk Evaluation
(EuroSCORE) and perioperative mortality was predicted
with the logistic version of this risk stratification model
[16,17]. Serum creatinine (SCr) was measured preopera-
tively in mg/dL at the day of hospital admission. Postoper-
ative the peak SCr value 24 hours after surgery was
analysed. Glomerular filtration rate (GFR) was calculated
with the abbreviated Modification of Diet in Renal Disease
(MDRD) formula and expressed in mL/min/1.73 m2:
MDRD-eGFR = 186.3 × SCr –1.154 × age –0.203 [18].
Oliguria was defined as urine output < 500 mL within 24 -
hours. Postoperative acute kidney injury was defined as a
decrease of glomerular filtration rate ≥ 50% or the need of
dialysis due to oliguria. The diagnosis of pneumonia was
based on clinical presentation, chest X-ray and positive
sputum cultures. Postoperative respiratory failure was de-
fined as severe decline of arterial pO2 < 50 mmHg, an
increase in pCO2 > 60 mmHg and an increase in respira-
tory rate > 40/min. Postoperative central neurologic event
included transient/prolonged ischemic neurological deficit
and stroke.Study endpoints
The primary study endpoint was postoperative mortality
defined as death within 30 days after operation. The
secondary endpoint was postoperative morbidity during
hospitalization, which were as follows: low cardiac output
syndrome (LCOS), respiratory failure, prolonged mechan-
ical ventilation, central neurologic event or requirement of
renal replacement therapy.Surgical management and perfusion techniques
Full midline sternotomy was routinely done and all
patients were operated on cardiopulmonary bypass by
standard cannulation of the ascending aorta and the
right atrium (two-stage cannula). Mild hypothermia was
applied and complete cardiac arrest was induced using
Calafiore’s blood cardioplegia. During conventional car-
diopulmonary bypass (CPB) blood was collected in an
open cardiotomy reservoir and afterwards transfused
back to the patient. At the end of harvesting the left
internal mammary artery (LIMA), heparin (350 IE/Kg)
was administered to target an activated clotting time
(ACT) of ≥ 450 seconds in patients with CECC. The
MECC-system (Maquet, Rastatt, Germany) is a fully
closed circuit without blood-air contact. The tube set
was pre-connected and completely coated with heparin.
The prime volume was 500 mL and no heparin was
added. For MECC heparin (125 IE/kg) was administered
after LIMA preparation targeting an ACT between 250
and 300 seconds because of the reduced artificial
surface. Blood was saved only with cell saver. Distal
anastomoses were done using 7–0 or 8–0 monofilament
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nized with protamine sulfate.
Anesthesia was maintained with inhalational and intra-
venous agents. Postoperatively, all patients were trans-
ferred to the intensive care unit (ICU) and received
standard monitoring and mechanical ventilation.
Statistical analysis
Statistical analysis was done with Stata 10.1 SE (Stata
Corp., College Station, USA). Figures were created either
with Stata or SigmaPlot 12.5 (Systat Software Inc., San
Jose, USA). Stata’s module psmatch2 [19] was used for
propensity score matching and covariate imbalance test-
ing. Continuous variables were first tested for normality
with the Shapiro-Wilk test and visually with Quantile-
Quantile plots. If normally distributed, they are presented
as mean ± standard deviation (SD), otherwise as median
with interquartile range (25th and 75th percentile).
Student’s t test was used for comparison of two continu-
ous, normally distributed variables, whereas Wilcoxon’s
ranksum test was taken for non-normally distributedTable 1 Unadjusted, i.e. before matching, pre- and operative
Variable CECC (
Age [years] 68.4 ±
Age group [n; %]
<59 3
60 -69 6
70-79 5
>80 2
Male gender [n; %] 129; 7
Logistic EuroSCORE [%, 95% CI] 16.0 (13.4
Ejection fraction [%] 50 (4
Height [cm] 172 (16
Weight [kg] 82 (7
Atrial fibrillation, preoperative [n; %] 9; 5
COPD, preoperative [n; %] 17; 9
Inhalative β2-Mimetic use [n; %] 5; 2
Myocardial infarction preoperative [n; %] 140;
Troponin I preoperative [ng/mL)A 5.1 (1.0
Insulin-dependent diabetes [n; %] 15; 8
Non insulin-dpendent diabetes [n; %] 26; 1
Diabetic nephropathy [n;%] 9, 5
Serum creatinine, preoperative [mg ×dL-1] 1.0 (0
Estimated GFR < 60 mL × min-1 × 1.73 m-2 [n; %] 63;
No of grafts [n] 2.95 ±
LIMA use [n; %] 126;
Bypass time [min] 96 (69
Aortic cross clamp time [min] 47 (3
A – Reference values (0.01 ng/ mL to 0.1 ng/mL).variables. Categorical data were shown as frequency distri-
butions and were analyzed with Fisher’s exact test for 2 ×
2 tables or with the Chi-Square test.
Because patients in this study were not randomly
assigned to CABG with MECC, we matched them based
on their propensity (conditional probability) to undergo
CABG with MECC. The propensity score (PS) is a sub-
ject’s probability of receiving a specific treatment condi-
tional on the observed covariates. The PS was calculated
by binary logistic regression including all variables
marked with an asterisk in Table 1. Nearest neighbor
matching with a caliper ε=0.25×σP (σP denotes standard
deviation of the estimated PS) was used to match 100
patients in the MECC group to 100 patients from the
CECC group (matching efficacy 68.5%; 100/146 of
MECC patients; 100 pairs). We used non-replacement
that is, one a treated case is matched to one non-treated
case, both cases were removed from the pool. We de-
fined logit=log((1-PS)/PS) as propensity score and used
it for matching. The logit of PS is called linear predictor
of the PS.data
n=175) MECC (n=146) p-value
9.74 67.8 ± 8.74 0.55
2 25 0.59
4 54
6 54
3 13
3.7% 113; 77.3% 0.44
to 18.2) 12.8 (10.9 to 14.6) 0.07
0; 64) 56 (45; 70) 0.001*
5; 176) 172 (166; 176) 0.65
3; 93) 80 (70; 90) 0.11
.1% 6; 4.1% 0.66
.7% 9; 6.1% 0.24
.9% 4; 2.7% 0.94
80% 116; 79.4% 0.90
to 21) 3.8 (0.4 to 0.7) 0.15
.6% 11; 7.6% 0.73
4.8% 21; 14.3% 1.0
.1% 5; 3.4% 0.45
.8; 1.3) 0.9 (0.8; 1.2) 0.05*
36% 32; 22% 0.006
0.88 2.7 ± 0.80 0.006*
72% 121; 83% 0.02*
; 119) 74 (54; 93) < 0.0001*
4; 61) 37 (27; 50) 0.0002*
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tients operated with CECC (n=175) was 0.399 ± 0.168
and in those receiving CABG with MECC 0.524 ± 0.156
with an associated standardized difference of 77.1% (95%
CI 54 to 99; t test p-value < 0.0001). After matching, the
mean PS for MECC use in the matched patients not re-
ceiving MECC was 0.471 ± 0.144 and in those receiving
MECC was 0.474 ± 0.135 which yielded a standardized
difference of 2.1% (95% CI −2.6 to 2.9; p > 0.05 for a
two-tailed test).
Figure 1 displays the distribution of estimated propen-
sity scores stratified to treatment (MECC) or control
(CECC).
Covariate imbalance was tested using the standardized
difference before and after matching together with the
achieved percentage reduction in absolute bias. The
standardized difference is the difference of the sample
means in the treated and non-treated sub-samples as a
percentage of the square root of the average of the sam-
ple variances in the treated and non-treated groups.
The average treatment effect for the treated (ATT)
answers the question: Is MECC beneficial for those indi-
viduals, who were (not randomly) assigned to treatment,
i.e. MECC and was estimated with Wilcoxon’s signed
rank test for continuous variables or with McNemar’s
test for risk differences to account for the paired data
structure after matching. We also calculated the average
treatment effect that answers the question if MECC is
beneficial for those randomly drawn from the overall
population. Bootstrapping (400 replications) was used to
estimate 95% confidence intervals (CIs) for ATEs. The
key notion is ATT≠ATE and they are linked via ATE =
N1/N × ATT + N0/N × ATU (N0 denotes the number of
non-participants, N1 denotes the number of participantsFigure 1 Box plot of estimated native propensity score (not the
logit of PS) stratified to type of extracorporeal circulation. There
is a sufficient overlap of propensity scores between both groups.
MECC, Minimized extracorporeal circulation; PS, propensity score.and ATU is the average treatment effect for the non-
participants.
Hidden bias was estimated according to Rosenbaum’s
sensitivity analysis. We used Stata’s rbounds module [20]
for this test.
Results
Patient characteristics
Unadjusted baseline data before matching were summa-
rized in Table 1. Several pre- and operative data were
significantly different between both groups, including
ejection fraction, renal function and LIMA use. It may
reflect the non-randomized study design. Whereas EF
was slightly higher in the MECC group, bypass and
cross-clamp time were longer in the CECC group.
After matching, treated patients were similar in terms of
all baseline covariates used for PS estimation (Table 2).
Matching reduced covariate imbalance and improved
covariate balance between treatment groups. The me-
dian absolute bias before matching was 32.6% and after
matching 5.9%.
Outcome
The unadjusted 30-day mortality was 14.8% (26/175) in
the CECC group and 6.9% (10/146) in the MECC group
(mean difference −7.9%; p=0.032). After matching, the
mean difference was −1.0% (95% CI −8.6 to 7.6; p=1.0)
and shows no survival benefit for emergency patients,
who were primarily assigned to MECC. If randomly drawn
from the overall population, emergency CABG with
MECC also does not exert a survival benefit (ATE; -1.5%;
95% CI −8.1 to 5.8; p > 0.05).
Table 3 summarizes the results for the secondary out-
come variables ICU-stay, hospital stay and postoperative
low cardiac output syndrome. Both ATT and ATE for all
three variables failed to demonstrate benefits for MECC.
Unadjusted in-hospital mortality was 13.7% (24/175)
in the CECC group and 5.5% (8/146) in the MECC
group (mean difference – 8.8%; p=0.015). The ATE was
estimated with −1.1% (95% CI −7.1 to 6.4; p=1.00) and
the ATE was estimated with −1.0% (95% CI −8.1 to 3.8).
Other outcome measures included postoperative venti-
lation time, drain loss, frequency of rethoracotomy and
incidence of in-hospital neurologic event, new onset
temporary renal replacement therapy (RRT) and inci-
dence of respiratory failure. Before matching, the median
postoperative ventilation time was 14 (9; 60) hours in
the CECC group and 12 (8; 20) hours in the MECC
group (p=0.05). After matching the average treatment
effect of the treated (ATT) was 20 hours (95% CI −2.4 to
72; p > 0.05) showing no benefit for those, who were pri-
marily assigned to MECC. The ATE was 13.2 hours
(95% CI −16.8 to 48.7; p > 0.05). Table 4 displays the
results of the average treatment effects for the treated
Table 2 Covariate balance testing between unmatched and matched sample
Variable Standardized difference [%] % reduction |difference| p-value
Unmatched Matched Unmatched Matched
Ejection fraction 44.6 0.3 99.4 0.02 0.98
Serum creatinine −18.3 8.3 54.6 0.14 0.28
No of grafts −26.5 22.1 16.6 0.03 0.11
LIMA use 31.1 2.6 91.5 0.01 0.85
Bypass time −66.3 3.7 94.5 < 0.0001 0.78
Cross clamp time −34.1 8.9 73.9 0.005 0.52
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variables. Since all confidence intervals for both ATT
and ATE include a zero (p > 0.05 for a two-tailed test),
there is no significant difference between MECC and
CECC after matching to be expected. In other words,
emergency patients with identical risk and revasculariza-
tion have similar outcomes after CABG irrespective
CECC or MECC use.
The frequency of rethoracotomy was almost 10% in
both groups and the most common reason was postop-
erative bleeding (80%) followed by hematoma. Postop-
erative low cardiac output was treated either with
intra-aortic ballon pump (n=2 in the MECC group; n=4
in the CECC group) or with veno-arterial ECMO (n=8 in
the CECC group).
Sensitivity analysis
Selection bias remains the most challenging analytic
problem in observational studies and thus, we conducted
a sensitivity analysis using Rosenbaum’s approach. UsingTable 3 Estimated average treatment effects on several outco
Comparison Outcom
ATTA 30-day m
[%]
CECC versus MECC
CECC (n=175) 14.8
MECC (n=146) 6.9
Unadjusted mean difference −7.9
p-value 0.03B
Adjusted mean difference after matching of 100 pairs (95% bias
corrected CI)
−1.0 (−8.
p-value 1.0C
ATED
Adjusted mean difference with 95% bias corrected CI) −1.5 (−8.
A – ATT Average treatment effect for the Treated.
B – Fisher’s exact test.
C – McNemar’s test.
D – ATE Average treatment effect.
E – The 95% bias corrected confidence interval does include a zero, or p > 0.05 for
F – Wilcoxon’s signed rank test.Wilcoxon’s signed rank test, the sensitivity analysis
showed that our study becomes sensitive to hidden bias
at Γ = 1.8 for 30-day mortality, at Γ = 1.5, at Γ = 1.2 and
at Γ = 2.5 for low cardiac output syndrome. Because
these values are small, we conclude that the study is
quite sensitive to hidden bias and therefore further ana-
lysis that control for additional biases is warranted.
Discussion
Emergency CABG should be performed in patients with
cardiogenic shock due to left main or severe triple vessel
disease and whenever PCI is unlikely to achieve
complete revascularization [21]. However, the applica-
tion of different revascularization techniques to patients
undergoing emergency CABG remains controversial.
Data on optimal treatment strategies are still lacking and
the logistic EuroSCORE as a tool for risk stratification is
suggested to overestimate mortality in emergency pa-
tients [22]. Emergency procedures are associated with an
enhanced perioperative risk, mainly caused by patient’sme variables
e measures
ortality ICU-stay [days] Hospital stay
[days]
Low cardiac output
[%]
5.3 13 11.4
4.6 12 5.6
−0.8 −1 −5.8
0.11 0.80 0.07B
6 to 7.6) 1.0 (−0.21 to 3.24) 1.0 (−2 to 3.6) −1.1 (−7.3 to 7.1)
0.70F 0.40F 0.83C
1 to 5.8)E 0.61 (−0.7 to 2.2)E 0.34 (−2.5 to 2.6)E −1.7 (−7.1 to 6.5)E
a two-tailed test.
Table 4 Secondary outcome measures
Variable Unadjusted
CECC MECC ATT (95% CI) ATE (95% CI)
Drain loss in 24 h [mL] 625 (350; 1100) 600 (350; 1000) 161 (−111 to 464) 164 (−109 to 406)
Rethoractomy [%] 9.7 8.9 3.2 (−4.9 to 12.1) 1.5 (−6.2 to 9.3)
Neurological event [%] 4.6 1.4 4.3 (−1.0 to 1.2) −4.0 (−8.6 to 2.3)
New onset RRT [%]A 8.6 5.5 2.1 (−5.8 to 8.2) 2.5 (−3.2 to 8.5)
Respiratory failure [%] 15.4 13.0 3.2 (−2.4 to 14.9) 1.5 (−4.3 to 14.3)
A – RRT Renal replacement therapy.
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arrest may contribute to surgical complications and
mortality [12]. Some previous studies reported improved
outcome for those patients operated upon beating heart
or off-pump [14,15,23] with mortality rates comparable
to patients operated upon on-pump [24].
To the best of our knowledge, there are no studies that
examine the impact of minimized circuits on outcome
after emergent CABG surgery compared to conventional
ECC. Propensity score methods are increasingly being
used to reduce the impact of treatment-selection bias in
the estimation of causal treatment effects in observational
studies [25,26]. We used propensity score matching to
estimate the treatment effect of MECC for emergency
CABG procedures because the comparison of the
unadjusted data showed significant bias. After matching
we failed to demonstrate benefits for MECC in terms of
survival, ICU and hospital stay, LCOS, postoperative
ventilation, new onset renal replacement therapy among
several others. Although our primary sample comprised
only 321 patients and we achieved a moderate matching
efficiency of 69%, the resulting pairs were very comparable
with a very low standardized difference of the PS.
The unadjusted data indicate an imbalance in patient
selection, i.e. MECC patients had a better EF, a lower
number of grafts, a somewhat higher LIMA use and
shorter bypass and cross-clamp times. Thus, improved
outcome may be expected. A question of concern arose
from the overall low LIMA use and it was not possible
to address this issue entirely. Analysis of patient records
mentioned hemodynamic instability in majority of pa-
tients and inappropriateness of vessel diameter or flow
in some cases. In the minority of cases, the decision to
use LIMA or not, however, was an individual surgeon
decision but gives room for improvement.
In non-emergency patients, MECC was shown to exert
some benefit in terms of postoperative renal function,
transfusion requirement and neurological dysfunction
[27,28]. We failed to show these effects in our matched
cohort since new onset RRT and incidence of cerebral
event did not differ. We did not specifically address the
issue of transfusion requirement because the majority of
our patients received multiple anticoagulants beforesurgery and usually, RBC and plasma transfusions are
more frequently seen in this patient group.
However, even advanced statistical methods to adjust
imbalance between control and treatment in observa-
tional studies cannot compensate the current lack of at
least one sufficiently powered randomized multicenter
trial to estimate outcomes of emergency CABG with
MECC and CECC. The mechanism why MECC might
be associated with reduced mortality is still speculative
and ranges from improved myocardial protection
through consequent use of blood cardioplegia, reduced
transfusion requirement, less pronounced inflammatory
response, to selection of healthier patients. Critics of
minimized ECC also may question whether small clinical
effects justify a more complex procedure with learning
curves and more intense and challenging interplay
between surgeon, anesthesiologist and perfusionist.
The unadjusted 30-day mortality, particularly in the
CECC group appears quite high. However, other studies
also report data of approximately 10% [23] and 11.4%
[29] and thus our reported total mortality of 11.8% is in
line with these reports, but offers room for improve-
ment. Since after matching the discrepancy between
both groups almost disappeared, it seems that some
patients in the CECC group had unmeasured comorbid-
ity that might have contributed to excessive mortality.
The interplay between proper patient selection, pre-
and perioperative stabilization including medical treat-
ment and optimal surgical technique remain mandatory
to address this high-risk patient group.
Strength and limitations
Findings from propensity score analyses might be poten-
tially limited by biases related to unmeasured and hid-
den covariates. Since our sensitivity analysis showed low
values for Γ for several outcome variables, it is likely that
unmeasured covariates contribute to our results and re-
quire further research. Incomplete or inexact matching
might also affect study results. Our matching efficiency
was almost 70% of all MECC patients, but still contrasts
other PS studies with matching efficiencies < 50%. On
the other hand, those matched were very comparable
and enabled direct analysis.
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We could not demonstrate significant different treatment
effects for patients undergoing emergency revascula-
rization with minimized or conventional extracorporeal
circulation. The findings of our study, based on a non-
randomized design, are largely hypothesis generating and
call for at least one randomized, multicenter trial using a
current risk score for precise uniform evaluation of coron-
ary pathology and predefined criteria for perioperative
care. Thus, routine MECC use for emergency CABG
currently may not be indicated.
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